| Name | Title | Contact Details |
|---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Accugen Laboratories Inc is a Willowbrook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bio Compression Systems Inc is a Moonachie, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At Footprints to Recovery, our mission is to transform your life of addiction to a life of hope through inspiration, education, and support. We`re an individual focused and evidenced based addiction rehabilitation center, that emphasizes meaningful connections in recovery. We are conveniently located in Hamilton, NJ and Arlington Heights, IL.
Willow River Farms is a Brookshire, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.